First Trust Advisors LP Emergent Bio Solutions Inc. Transaction History

First Trust Advisors LP

$101 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$7.79 - $16.29 $835,376 - $1.75 Million	107,237 Added 47.35%	333,725 $3.46 Million
Q4 2022 Feb 09, 2023	BUY	$11.0 - $21.45 $881,870 - $1.72 Million	80,170 Added 54.79%	226,488 $2.67 Million
Q3 2022 Nov 14, 2022	BUY	$20.09 - $35.8 $210,744 - $375,541	10,490 Added 7.72%	146,318 $3.07 Million
Q2 2022 Aug 12, 2022	BUY	$27.42 - $43.63 $385,141 - $612,826	14,046 Added 11.53%	135,828 $4.22 Million
Q1 2022 May 13, 2022	BUY	$36.48 - $52.22 $1.15 Million - $1.64 Million	31,451 Added 34.82%	121,782 $5 Million
Q4 2021 Feb 08, 2022	BUY	$33.11 - $55.01 $2.52 Million - $4.18 Million	76,005 Added 530.54%	90,331 $3.93 Million
Q3 2021 Nov 15, 2021	SELL	$50.07 - $66.05 $1.25 Million - $1.64 Million	-24,880 Reduced 63.46%	14,326 $717,000
Q2 2021 Aug 16, 2021	SELL	$56.61 - $80.46 $11,888 - $16,896	-210 Reduced 0.53%	39,206 $2.47 Million
Q1 2021 May 14, 2021	SELL	$86.23 - $125.19 $1.25 Million - $1.81 Million	-14,447 Reduced 26.82%	39,416 $3.66 Million
Q4 2020 Feb 02, 2021	BUY	$79.17 - $111.47 $4.26 Million - $6 Million	53,863 New	53,863 $4.83 Million
Q2 2020 Jul 22, 2020	SELL	$54.33 - $89.52 $1.52 Million - $2.5 Million	-27,929 Closed	0 $0
Q1 2020 May 06, 2020	SELL	$49.34 - $68.76 $926,210 - $1.29 Million	-18,772 Reduced 40.2%	27,929 $1.62 Million
Q4 2019 Feb 03, 2020	BUY	$51.21 - $59.06 $1.04 Million - $1.2 Million	20,277 Added 76.74%	46,701 $2.52 Million
Q3 2019 Nov 04, 2019	BUY	$40.6 - $57.2 $1.07 Million - $1.51 Million	26,424 New	26,424 $1.38 Million
Q2 2019 Jul 30, 2019	SELL	$39.92 - $53.86 $2.54 Million - $3.43 Million	-63,662 Closed	0 $0
Q1 2019 May 09, 2019	SELL	$48.23 - $66.16 $222,388 - $305,063	-4,611 Reduced 6.75%	63,662 $3.22 Million
Q4 2018 Feb 07, 2019	BUY	$55.63 - $73.24 $2.4 Million - $3.16 Million	43,080 Added 171.0%	68,273 $4.05 Million
Q3 2018 Oct 25, 2018	SELL	$52.05 - $66.51 $1.57 Million - $2.01 Million	-30,151 Reduced 54.48%	25,193 $1.66 Million
Q2 2018 Aug 02, 2018	BUY	$48.33 - $55.64 $632,108 - $727,715	13,079 Added 30.95%	55,344 $2.79 Million
Q1 2018 Apr 23, 2018	BUY	$44.44 - $54.39 $7,999 - $9,790	180 Added 0.43%	42,265 $2.23 Million
Q4 2017 Feb 08, 2018	BUY	$37.77 - $47.75 $238,819 - $301,923	6,323 Added 17.68%	42,085 $1.96 Million
Q3 2017 Oct 24, 2017	BUY	$34.14 - $40.45 $1.22 Million - $1.45 Million	35,762	35,762 $1.45 Million

Others Institutions Holding EBS

# of Institutions

160

Shares Held

33.8M

Call Options Held

453K

Put Options Held

931K

Black Rock Inc. New York, NY

3.84M
Shares

$32.3 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.4M
Shares

$28.6 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.49M
Shares

$21 Million
0.03% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

2.22M
Shares

$18.7 Million
0.0% of portfolio
State Street Corp Boston, MA

1.91M
Shares

$16.1 Million
0.0% of portfolio

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $420M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account